KLRS Q2 2022 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$180M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$426,000

Operating Income

-$45M

Net Income

-$45M

EPS (Diluted)

$-15.93

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$200M

Total Liabilities

$42M

Stockholders' Equity

$158M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$426,000	-$33,000	-1190.9%
Operating Income	-$45M	-$38M	-18.5%
Net Income	-$45M	-$38M	-18.8%